作者: Britt C Reid , Anthony J Alberg , Ann C Klassen , R.Gary Rozier , Isabel Garcia
DOI: 10.1016/S1368-8375(01)00044-6
关键词:
摘要: We explored differences in prognostic ability for mortality of the established and validated Charlson comorbidity index with two other indexes developed this study. Our study was limited to persons diagnosed HNCA between 1985 1993 a database formed by linkage files from National Cancer Institute's Surveillance, Epidemiology, End Results Program Health Care Finance Administration Medicare (n=9386). Adjusted relative risks (RR) 95% confidence intervals (95%CI) scores 1 or more compared 0 were (RR=1.50, CI 1.43–1.68) index, (RR=1.53 1.42–1.66) (RR=1.49, 1.32–1.68) ATC respectively. The displayed dose-response patterns (P-value trend <0.0001). Although appears promising, had similar adjusted RR's, patterns, P-values, chi-square appear particularly well-suited measurement comorbidity.